June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
The Protective effects of Resveratrol in Experimental Retinal Detachment
Author Affiliations & Notes
  • Wei Huang
    Ophthalmology, Duke Eye Center, Durham, NC
  • Guorong Li
    Ophthalmology, Duke Eye Center, Durham, NC
  • Jianming Qiu
    Ophthalmology, Duke Eye Center, Durham, NC
  • Pedro Gonzalez
    Ophthalmology, Duke Eye Center, Durham, NC
  • Pratap Challa
    Ophthalmology, Duke Eye Center, Durham, NC
  • Footnotes
    Commercial Relationships Wei Huang, None; Guorong Li, None; Jianming Qiu, None; Pedro Gonzalez, None; Pratap Challa, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4198. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Wei Huang, Guorong Li, Jianming Qiu, Pedro Gonzalez, Pratap Challa; The Protective effects of Resveratrol in Experimental Retinal Detachment. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4198.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To investigate whether Resveratrol, a potent antioxidant and small molecule activator of the FoxO pathway, would be neuroprotective against photoreceptor cell death in a rodent model of retinal detachment (RD).

Methods: Retinal detachment was created in adult Brown Norway rats by subretinal injection of sodium hyaluronate. The animals were treated daily with vehicle, Resveratrol (20mg/kg) intraperitoneal injection. Photoreceptor death was assessed by counting the number of apoptotic cells with TdT-dUTP terminal nick-end labeling (TUNEL) and measurement of the outer nuclear layer (ONL) thickness 3 days after RD. Changes in expression of FoxO1A, FoxO3A, and FoxO4 were analyzed by western blot. The activity of Caspase 3, Caspase 9, Spectrin and their cleavage forms were studied.

Results: Three days after RD, Caspase 3, Caspase 9 were activated. There was no activation of a 120 kDa form of Spectrin, Calpain specific substrates, detected. Resveratrol treatment increases FoxO1A, FoxO3A, and FoxO4 protein, a family of transcription factors known to regulate the defense against reactive oxygen species, expression in RD retina. Resveratrol treatment partially blocks Caspases activation. Resveratrol significantly decreases the number of TUNEL-positive cells and preserves ONL thickness in both systemic only and systemic with local treatment group.

Conclusions: Resveratrol has potential be used as a novel therapeutic agent for preventing vision loss in diseases that are characterized by photoreceptor detachment.

Keywords: 424 antioxidants • 426 apoptosis/cell death • 648 photoreceptors  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.